VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 361 filers reported holding VANECK VECTORS ETF TR in Q2 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $205 | -10.5% | 7,600 | 0.0% | 0.03% | -8.6% |
Q2 2023 | $229 | -99.9% | 7,600 | 0.0% | 0.04% | -12.5% |
Q1 2023 | $245,860 | +12.9% | 7,600 | 0.0% | 0.04% | +2.6% |
Q4 2022 | $217,816 | +4.7% | 7,600 | 0.0% | 0.04% | -7.1% |
Q2 2022 | $208,000 | -28.5% | 7,600 | 0.0% | 0.04% | -20.8% |
Q1 2022 | $291,000 | -5.2% | 7,600 | -20.8% | 0.05% | -5.4% |
Q4 2021 | $307,000 | +8.5% | 9,600 | 0.0% | 0.06% | 0.0% |
Q3 2021 | $283,000 | -13.2% | 9,600 | 0.0% | 0.06% | -13.8% |
Q2 2021 | $326,000 | +4.5% | 9,600 | 0.0% | 0.06% | -1.5% |
Q1 2021 | $312,000 | -9.8% | 9,600 | 0.0% | 0.07% | -18.5% |
Q4 2020 | $346,000 | -14.1% | 9,600 | -6.8% | 0.08% | -27.0% |
Q3 2020 | $403,000 | +6.6% | 10,300 | 0.0% | 0.11% | +3.7% |
Q2 2020 | $378,000 | +42.1% | 10,300 | -10.8% | 0.11% | +21.6% |
Q1 2020 | $266,000 | -21.3% | 11,550 | 0.0% | 0.09% | +3.5% |
Q4 2019 | $338,000 | +4.6% | 11,550 | -4.5% | 0.08% | -3.4% |
Q3 2019 | $323,000 | -11.7% | 12,100 | -15.4% | 0.09% | -11.1% |
Q2 2019 | $366,000 | +0.3% | 14,300 | -12.3% | 0.10% | -2.9% |
Q1 2019 | $365,000 | -11.4% | 16,300 | -16.6% | 0.10% | -22.7% |
Q4 2018 | $412,000 | +12.0% | 19,550 | -1.5% | 0.13% | +33.3% |
Q3 2018 | $368,000 | -21.5% | 19,850 | -5.5% | 0.10% | -26.1% |
Q2 2018 | $469,000 | +1.5% | 21,000 | 0.0% | 0.13% | +0.8% |
Q1 2018 | $462,000 | -13.6% | 21,000 | -8.7% | 0.13% | -13.1% |
Q4 2017 | $535,000 | -0.9% | 23,000 | -2.1% | 0.15% | +0.7% |
Q3 2017 | $540,000 | -33.6% | 23,500 | -36.1% | 0.15% | -31.8% |
Q2 2017 | $813,000 | -23.5% | 36,800 | -21.0% | 0.22% | -26.2% |
Q1 2017 | $1,063,000 | +9.0% | 46,600 | 0.0% | 0.30% | +3.1% |
Q4 2016 | $975,000 | -21.7% | 46,600 | -1.1% | 0.29% | -29.7% |
Q3 2016 | $1,245,000 | -10.9% | 47,100 | -6.5% | 0.42% | -10.3% |
Q2 2016 | $1,397,000 | – | 50,400 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |